PPD is the ideal consulting partner to assist with your biopharmaceutical product’s success from discovery through post-approval.
Expertise in nearly 40 psychiatric and neurological disorders, and clinically trained neuroscience teams led by scientists and clinicians with extensive neuroscience experience.
PPD's Phase I clinic in Austin, Texas, conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers. This is not testing to determine if the medicine works.
Read a case study about a Phase I-III clinical development program to assess the efficacy and safety of a glucagon-like peptide-1 (GLP-1) in the treatment of Type 2 diabetes mellitus (T2DM).
Get information about PPD posted on industry websites and publications.
Learn about our company culture and how we have a global impact.
PPD’s innovative technology, capabilities and extensive experience support REMS programs.
Learn more about PPD’s available study opportunities and how you can help advance medical research.
PPD delivers the optimal clinical strategy, global resources and therapeutic expertise.
PPD’s site intelligence and activation group streamlines clinical research timelines.
Learn how PPD strives to be a good steward of company and community resources around the globe.
PPD brings innovation, technology and expertise to hematology and oncology trials.
From discovery through post-approval, new medicines progress through a rigorous process.
© 2014 Pharmaceutical Product Development, LLC. All rights reserved.